HIGHLIGHTS
- who: Katarina Dathe from the Platz, Berlin, Germany have published the research work: Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort, in the Journal: (JOURNAL) of 14/08/2018
- what: The aim of this study was, therefore, to assess the risk of defined fetal adverse effects and pregnancy outcome after exposure to NSAID and/or metamizole in the 2nd and 3rd trimester, with a specific focus on 2nd trimester exposure.
- how: Approximately 8 weeks after the expected date of delivery . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.